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Abstract
Objectives: HIV infection is associated with an increased risk of age-related morbidity mediated by immune dysfunction,
atherosclerosis and inflammation. Changes in retinal vessel calibre may reflect cumulative structural damage arising from
these mechanisms. The relationship of retinal vessel calibre with clinical and demographic characteristics was investigated
in a population of HIV-infected individuals in South Africa.
Methods: Case-control study of 491 adults $30 years, composed of 242 HIV-infected adults and 249 age- and gender-
matched HIV-negative controls. Retinal vessel calibre was measured using computer-assisted techniques to determine
mean arteriolar and venular diameters of each eye.
Results: The median age was 40 years (IQR: 35–48 years). Among HIV-infected adults, 87.1% were receiving highly active
antiretroviral therapy (HAART) (median duration, 58 months), their median CD4 count was 468 cells/mL, and 84.3% had
undetectable plasma viral load. Unadjusted mean retinal arteriolar diameters were 163.67617.69 mm in cases and
161.34617.38 mm in controls (p = 0.15). Unadjusted mean venular diameters were 267.77618.21 mm in cases and
270.81618.98 mm in controls (p = 0.07). Age modified the effect of retinal arteriolar and venular diameters in relation to HIV
status, with a tendency towards narrower retinal diameters in HIV cases but not in controls. Among cases, retinal arteriolar
diameters narrowed with increasing duration of HAART, independently of age (167.83 mm,3 years of HAART vs. 158.89 mm
.6 years, p-trend = 0.02), and with a HIV viral load .10,000 copies/mL while on HAART (p = 0.05). HIV-related venular
changes were not detected.
Conclusions: Narrowing of retinal arteriolar diameters is associated with HAART duration and viral load, and may reflect
heightened inflammatory and pro-atherogenic states of the systemic vasculature. Measurement of retinal vascular calibre
could be an innovative non-invasive method of estimating vascular risk in HIV-infected individuals.
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Introduction
HIV infection and highly active antiretroviral therapy
(HAART) exacerbate a range of systemic age-related conditions
such that HIV-infected patients are at increased risk of age-related
non-AIDS-related morbidity and mortality compared with HIV-
uninfected persons [1–3]. The emerging scenario is that of HIV
population cohorts who are aging chronologically, but also likely
to be undergoing accelerated physiological and immunological
senescence. Mechanisms underlying accelerated aging include
increased inflammation and immune dysfunction. The micro-
vascular circulation may reflect cumulative structural damage
arising from these processes. However, current methods to
investigate the micro-circulation are invasive and require specialist
expertise.
The retina represents a unique location where the micro-
vasculature can be directly and non-invasively visualised. Validat-
ed and objective quantitative measurement of retinal vessel
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diameters is possible using semi-automated software applied to
digitized retinal photographs [4]. This technique has been used in
several population-based studies, and is established as a valid and
efficient biomarker of systemic vascular disease [5–8]. Retinal
vascular calibre is considered a structural marker of vascular
pathology reflecting the interplay of systemic, environmental and
genetic factors [9]. For example, changes in arteriolar calibre are
strongly associated with chronological age, hypertension and
cardiovascular disease, whereas venular calibre changes represent
chronological age as well as inflammatory and cerebrovascular
diseases. [10,11]. Seemingly small reductions in retinal arteriolar
calibre are associated with clinically relevant changes in blood
pressure, e.g., a 10-mmHg increase in systolic BP is associated with
a 1.1 mm reduction in arteriolar calibre [12]. A 20 mm increase in
retinal venular calibre is associated with a coronary heart disease
hazard ratio of 1.16 (95% CI: 1.06–1.26) in women.
There is limited information regarding relationships between
retinal vessel calibre and HIV status, particularly in the context of
premature aging and risk of age-related co-morbidities such as
cardiovascular disease. Furthermore, data are lacking within sub-
Saharan Africa, a region where the population of older HIV-
infected persons is rapidly growing as individuals initiate HAART
at increasingly early stages of the disease [13]. Assessment of
retinal vessel calibre can provide a non-invasive and representative
model to objectively assess changes in the micro-circulation in
HIV infection and with HAART.
The objective of this study was to investigate the relationship of
retinal vessel calibre with clinical and demographic characteristics
in a cohort of HIV-infected individuals in South Africa in
comparison with a matched population of uninfected individuals.
We hypothesized that retinal vascular calibre would be altered in
patients with HIV, who are known to have both elevated
cardiovascular risk and chronic, systemic inflammation related to
HIV-related accelerated aging [14,15]. Cases and controls were
recruited from neighbouring townships in Cape Town. The
hypothesis of accelerated aging in HIV has received criticism
primarily due to limitations in characterization of participants, and
the possibility of differential exposure to potential risk factors (e.g.
smoking, substance abuse) between HIV-infected and uninfected
populations [16]. By recruiting from the same community, we
aimed to reduce the likelihood of differential risk exposure in line
with the recommendation for careful study design when investi-
gating premature aging in HIV [17].
Methods
Ethics Statement
The study was approved by the London School of Hygiene and
Tropical Medicine Ethics Committee and the University of Cape
Town Faculty of Health Sciences Ethics Committee, and adhered
to the tenets of the Declaration of Helsinki. Written informed
consent was obtained from all participants.
Study Participants
HIV-infected participants (cases) aged $30 years were enrolled
from a community-based HIV treatment centre in Nyanga district
of Cape Town [18,19]. All participants had a confirmed
serological diagnosis of HIV and were either about to commence
HAART (HAART-naı¨ve), or were already on first-line HAART.
A control group of HIV-uninfected participants was recruited
using frequency-matching by gender and 5-year age categories.
Controls were enrolled from participants confirmed to be HIV-
negative attending an HIV prevention trials site (Emavundleni
Centre), located within the same district as the HIV treatment
centre. These two centres were chosen as individuals attending
them were drawn from the same community and were therefore
likely to have similar socio-demographic characteristics.
Data Collection
Socio-demographic information and medical history were
obtained by questioning participants in their first language (Xhosa
or English). Clinical information was obtained from medical case
notes where required. Co-morbidity was defined as the concurrent
presence of one or more chronic diseases or conditions including
cardiovascular disease, chronic renal failure, airways disease and
malignancy (both AIDS and non-AIDS defining). Cardiovascular
diseases included myocardial infarction and cerebrovascular
disease. Blood pressure (BP) was measured with a digital
sphygmomanometer with a cuff of appropriate size. Mean arterial
blood pressure (MABP) was defined as two-thirds of the diastolic
plus one-third of the systolic BP. Hypertension was defined as a
systolic BP of 140mmHg or higher, diastolic BP of 90mmHg or
higher, or the combination of self-reported high BP diagnosis and
the use of anti-hypertensive medications [20]. Body mass index
(BMI) was defined as weight (in kilograms)/height2. HIV infection
characteristics including duration of HAART, type of HAART
regimen, nadir and current CD4 count and viral load (VL) were
available from the clinic database.
Retinal Vessel Measurement
All participants had stereoscopic 30 degree colour retinal
photographs taken of both eyes under pharmacological pupil
dilation with a fundus camera (model CF-2; Canon Inc., Tokyo,
Japan). Images were centred on the optic disc. Vessel calibre
indices were determined in a semi-automated manner using the
IVAN computer program (Singapore Eye Research Institute,
Singapore) using a standardized protocol described previously [4].
In summary, the 6 largest arterioles and venules in a ring-shaped
area located between 0.5 and 1.0 disc diameter from the optic disc
margin were identified (Figure 1). Computer software measured
the calibre of these individual vessels, then combined them into 2
summary variables for the eye: the projected calibre size of the
central retinal artery (central retinal artery equivalent [CRAE]),
and the projected calibre size of the central retinal vein (central
retinal vein equivalent [CRVE]), using formulas derived by Parr
and Spears [21,22] and Hubbard [23], with revision by Knudtson
[24]. A retinal photograph was considered ungradable if eyes had
,4 acceptable measurements of either vessel type. The inter-
grader and intra-grader grading reliabilities were assessed using a
random subsample of 100 photographs reviewed four weeks after
the initial grading. The intra- and inter-grader intraclass
correlation coefficients ranged from 0.71 to 0.93.
Data Analysis and Statistical Methods
If gradable images were available for both eyes, one eye was
randomly selected for vessel calibre assessment as good correlation
between eyes has been demonstrated using this software, and is
considered sufficient for assessing relationships to systemic health
status [25]. If there was only one gradable image, this one was
used, and if neither eye had a gradable image the participant was
excluded. Retinal vessel data (CRAE and CRVE) were analyzed
as continuous variables. Univariable linear regression was
performed to compare mean retinal arteriolar and venular
diameters respectively by gender and HIV status (no; yes).
Multivariable linear regression models were used to examine the
relationships of retinal vessel diameters as the dependent variable
with HIV status and explanatory variables (age group (30–39; 40–
49; .50 years), gender, mean arterial blood pressure; BMI,
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smoking and diastolic blood pressure). Models included an
interaction term between HIV and each explanatory variable.
Marginal adjusted means for retinal vessel diameters were
estimated at the mean value of covariates in the model. The
Wald test was used to assess statistical significance of the
interaction of HIV status with each explanatory variable on
retinal vessel diameter. Retinal arteriolar and venular calibre are
highly correlated, and to account for potential confounding we
adjusted for the fellow vessel in multivariable analyses (i.e.
adjustment for arteriolar calibre in analyses of venular calibre
and vice versa) [26]. All analyses were performed with Stata 12
(Stata Corp, USA).
Results
Participant Characteristics
491 participants were evaluated, of whom 242 had HIV-
infection, and 249 were uninfected controls. The mean age of the
HIV-infected population was 41.260.5 years, and 42.560.6 years
in the uninfected group (p = 0.10). Cases had lower BMI, were less
likely to be smokers, and more likely to have current or previous
TB than controls (Table 1). Overall, 72.7% of cases had a history
of WHO stage 3 or stage 4 defining illness. The current CD4
count among participants receiving HAART was 468 cells/mL
(interquartile range [IQR], 325–607 cells/mL) and 84.0% had
undetectable VL. Median treatment duration on HAART was 58
months (IQR: 34–75 months). 12.0% were HAART naı¨ve, and
had correspondingly lower CD4 counts and higher VL.
Retinal Photography and Vessel Grading
All participants underwent retinal photography. Photographs
were ungradable for retinal vessel diameters in 12 individuals
(2.4%), who were older than those with gradable photographs
(p = 0.001) but otherwise had similar characteristics (p.0.05 for all
characteristics; data not shown). The proportion of cases and
controls with ungradable photos was similar (2.48% vs. 2.41%;
p = 0.96).
Overall Retinal Vessel Measurements
Measurements are summarised in Table 2. The following
comparisons were not statistically different: arteriole diameters
between cases and controls, overall (p = 0.15) nor by gender
(p = 0.68 for males, p = 0.14 for females). However, venules were
narrower in cases than controls although this did not reach
statistical significance (p = 0.07). Male cases had significantly
narrower venules (265.72618.04 mm) than male controls
(274.55621.66 mm; p = 0.02) but this association was not seen in
females (p = 0.55).
Retinal Vessel Calibre and Association with HIV and Age
In unadjusted analyses, there was a significant trend of narrower
arteriolar diameters (P-trend = 0.002), and venular diameters (P-
trend = 0.001) with increasing age in the HIV-infected group, also
evident when stratified by gender (data not shown). This trend was
not seen consistently in the control group. Table 3 reports adjusted
mean vascular diameters by HIV status, stratified by other
covariates. In relation to mean arteriolar diameters, age and
hypertension status modified the association in relation to HIV
status (P values for interaction 0.01). Mean arteriolar diameters
tended to decrease with age among HIV-infected cases, and to
increase among controls. Among controls, those with hypertension
had wider arteriolar diameters than those without hypertension
(167.97 vs. 158.28 mm; p = 0.002), whereas among HIV cases
there was little association with hypertension (164.82 vs.
163.53 mm; p = 0.69). Mean venular diameter also decreased with
age among HIV cases, but there was no association among
controls (p-interaction = 0.07). In addition, venular diameter
tended to be greater among males than females, and smokers
than non-smokers among controls, but little difference was seen
among cases.
Retinal Vessel Calibre in HIV-infected Participants on
HAART
We investigated the associations between mean arteriolar and
venular diameter and clinical/demographic factors in participants
Figure 1. Retinal vessel grading assessment. Right: fundus with automated measurements (red = arterioles, blue = venules). Left: venular
diameters output.
doi:10.1371/journal.pone.0051405.g001
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on HAART (Table 4). There was a trend of increasing age being
associated with narrowing of retinal arterioles (P-trend = 0.08). A
longer duration of HAART was associated with narrowing of
arterioles. Mean arteriolar diameter ranged from 167.83 mm in
Table 1. Demographic characteristics of study population.
Variable Cases (242) % (n) Controls (249) % (n) P-value
Age (mean6SD) 41.260.5 42.560.6 0.10
Age (years) by group
30–39 49.2 (119) 47.0 (117) 0.54
40–49 33.5 (81) 31.7 (79)
.50 17.3 (42) 21.3 (53)
Male gender 25.6 (62) 24.1 (60) 0.70
Hypertension status
Hypertensive 27.3 (66) 29.3 (73) 0.62
Mean arterial blood pressure 94.37614.64 95.53613.90 0.37
BMI (kg/m2) 27.866.5 31.568.8 ,0.0001
Co-morbidity
None 71.1 (172) 69.5 (173)
One or more 28.9 (70) 30.5 (76) 0.70
Smoking status
Smoker 15.3 (37) 27.3 (68) 0.001
TB status
No history 30.6 (74) 88.0 (219) ,0.0001
Current 4.1 (10) 0.4 (1)
Previous 64.3 (158) 11.7 (29)
HIV characteristics (n=242) (%) n or median (IQR)
WHO stage
K 27.3 (66)
3/4 72.7 (176)
HAART naı¨ve 12.0 (29)
CD4 count in HAART naı¨ve group (n = 29) 170 (84–201)
Log10VL* in HAART naı¨ve group (n = 19) 4.81 (4.11–5.14)
Current CD4 count in HAART group 468 (325–607)
Nadir CD4 count in HAART group 127 (76–171)
% with detectable VL in HAART group 16.0 (34)
Peak Log10VL in HAART group 4.56 (3.84–4.98)
Duration of HAART, months 58 (34–75)
HAART Regimen
NNRTI-based* 59.6 (127)
Other 40.4 (86)
*VL = HIV RNA Viral load; NNRTI - non-nucleoside reverse transcriptase inhibitor;
doi:10.1371/journal.pone.0051405.t001
Table 2. Retinal vessel calibre in study population.
Mean arteriolar diameter Mean venular diameter
HIV+ cases Uninfected controls P-value HIV+ cases Uninfected controls P-value
Overall 163.67617.69 161.34617.38 0.15 267.77618.21 270.81618.98 0.07
Males 162.00617.68 160.53620.48 0.68 265.72618.04 274.55621.66 0.02
Females 164.24617.71 161.60616.33 0.14 268.47618.27 269.62617.94 0.55
Measurements are in mm and represent mean 6 standard deviation.
doi:10.1371/journal.pone.0051405.t002
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those with less than 3 years duration of HAART to 158.89 mm
with more than 6 years of treatment (P-trend = 0.02). A higher
current viral load while on HAART (.10,000 copies/ml) was
associated with narrower arterioles (p = 0.05). There was an
association of narrowed arterioles with hypertension (p = 0.03) in
this group, however this association was not apparent after
adjustment for HIV-related factors (data not shown). Venular
diameters narrowed with increasing age (P-trend = 0.02). A higher
current viral load was associated with wider venular diameters in
the unadjusted estimates (266.36 mm for VL ,10, 000 copies/ml
vs. 279.10 mm for VL.10,000 copies/ml (p = 0.02). The trend of
wider venules with higher viral load was apparent in the fully
adjusted model, but did not reach statistical significance (p = 0.20).
Discussion
We assessed retinal vessel calibre in HIV-infected individuals in
South Africa. This study provides clear evidence that retinal
arteriolar diameters narrow with increasing duration of HAART
and with higher HIV viral load, independently of age. The excess
age-related morbidity demonstrated in HIV-infected individuals
has a significant vascular component including cardiovascular,
renal and cerebrovascular disease, and retinal vessel calibre
measurement has been demonstrated as a strong biomarker of
systemic vascular disease.
We found an 8.9 mm decrease in arteriolar diameter in
participants who had been on HAART for .6 years after
adjustment for age and HIV-related factors. Our findings are in
alignment with data from the Longitudinal Studies of the Ocular
Complications of AIDS (LSOCA) [27], in particular, the
association of narrower retinal arteriolar diameter with exposure
to HAART. In our study population we additionally demonstrated
that retinal arteriolar diameter decreases with increasing duration
of HAART. The association of retinal arteriolar calibre with
cardiovascular risk is well documented. Retinal arteriolar diameter
(CRAE) is independently associated with increased carotid intima
thickness [12], and with higher cardiovascular mortality risk in
older persons [5,28]. An important cause of premature morbidity
and mortality in HIV-infected individuals is from cardiovascular
complications [29]. HAART-treated patients have a greater
prevalence of atherosclerosis and vascular dysfunction than age-
matched uninfected adults [30]. Enhanced endothelial dysfunction
(measured by flow-mediated dilation) and increased carotid intima
media thickness have been demonstrated in HIV cases compared
to controls, despite antiretroviral therapy and adjustment for
traditional CVD risk factors [31–35]. It is plausible that narrower
Table 3. Retinal Arteriolar and Venular Diameters in Relationship to HIV status, Stratified by Potential Effect Modifiers*.
Mean arteriolar diameter mm (SE) Mean venular diameter mm (SE)
HIV-infected
(n =236) Controls (n=243)
P-value for
interaction
HIV-infected
(n =236) Controls (n =243)
P-value for
interaction
Overall 163.95 (1.14) 161.08 (1.12) 268.17 (1.22) 270.43 (1.20)
Age group
30–39 165.86 (1.64) 161.27 (1.60) 0.01 271.34 (1.77) 269.49 (1.73) 0.07
40–49 163.47 (1.93) 157.94 (1.94) 265.59 (2.07) 271.43 (2.10)
.50 159.13 (2.72) 166.24 (2.55) 264.45 (2.92) 270.96 (2.75)
P-value 0.11 0.03 0.05 0.76
Sex
Male 161.02 (2.41) 158.29 (2.56) 0.22 266.68 (2.56) 276.13 (2.72) 0.02
Female 164.92 (1.34) 162.00 (1.36) 268.73 (1.44) 268.54 (1.44)
P-value 0.17 0.23 0.50 0.02
Cigarette use
No 163.73 (1.24) 160.21 (1.34) 0.16 268.46 (1.32) 268.69 (1.44) 0.03
Yes 164.20 (3.09) 163.93 (2.25) 265.47 (3.29) 275.69 (2.38)
P-value 0.89 0.17 0.41 0.01
Hypertension status
No 163.53 (1.45) 158.28 (1.42) 0.01 270.21 (1.57) 271.86 (1.54) 0.38
Yes 164.82 (2.60) 167.97 (2.46) 262.94 (2.78) 266.70 (2.66)
P-value 0.69 0.002 0.04 0.12
BMI
,20 166.73 (3.71) 166.06 (4.36) 0.13 262.20 (3.96) 274.52 (4.66) 0.77
20–24.9 166.48 (2.20) 159.24 (2.75) 266.10 (2.36) 267.22 (2.94)
25–29.9 160.77 (2.04) 160.77 (2.43) 266.56 (2.19) 270.04 (2.60)
.30 163.95 (2.00) 161.18 (1.55) 271.78 (2.14) 271.93 (1.66)
P-value 0.24 0.59 0.11 0.41
Adjusted for gender, age, hypertension status, smoking status, BMI, diastolic BP and associate vessel diameter (i.e. CRVE for CRAE analyses, and CRAE for CRVE analyses),
categorised as shown in the Table.
CRAE/CRVE = Central retinal artery equivalent/central retinal vein equivalent.
doi:10.1371/journal.pone.0051405.t003
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retinal arteriolar diameter is related to excess cardiovascular risk in
patients on HAART. The risk of cardiovascular disease appears to
be greatest with protease inhibitors (PIs) compared to non-
nucleoside reverse transcriptase inhibitors (NNRTIs) [36,37]. The
majority of our study population were treated with NNRTIs, and
we postulate that the magnitude of arteriolar narrowing might be
greater in populations where treatment is PI-based.
Higher viral load while on HAART (.10,000 copies/mL) was
associated with wider venular calibre in unadjusted estimates; this
trend remained in an adjusted model, but did not achieve
statistical significance. Endothelial dysfunction is associated with
larger retinal venules independent of traditional cardiovascular
risk factors [38]. Larger venular calibre is also associated with
higher levels of inflammatory markers such as interleukin-6
[39,40]. We postulate that in our HIV-infected population higher
HIV viral loads may cause inflammation and/or endothelial
dysfunction manifest as retinal venular dilation. The association of
narrow venular diameter with increasing age was stronger in an
adjusted model. This may reflect lack of statistical power, or
possibly that the ‘aging’ phenotype plays a larger role in
determining venular calibre in HIV. Narrow arteriolar calibre is
also associated with inflammation in diabetes possibly explaining
the finding of narrower CRAE with higher viral load [11].
The strong association between increasing age and narrowed
retinal vessels has been demonstrated in several study populations
[41–43]. This association was demonstrated in our cohort of HIV-
infected individuals, and in a US HIV population [27]. We
hypothesized that retinal vascular changes typically occurring in
older populations might occur earlier in life in HIV-infected
individuals. For venular diameters this appears to be consistent,
however, this trend was not apparent in retinal arterioles. The
interaction of age with HIV status in determining retinal arteriolar
diameter is novel and biologically difficult to explain. Graders
were masked to the HIV status of the participants, and mis-
grading would have caused random misclassification. There may
be residual confounding and bias accounting for this finding, or
this scenario could have occurred by chance. The effect of age in
relation to HIV status, and possible effect modification warrants
further investigation.
The strengths of this study include the high proportion of
gradable digital retinal photographs, and use of a well-established,
standardized computer-based technique to measure retinal vascu-
Table 4. Retinal vessel diameters in association to HIV-related factors in participants on HAART.
Arteriolar diameter (n=207) Venular diameter (n =207)
N Mean (SE), mm P Mean (SE), mm P
Age group (years)
30–39 99 164.81 (1.87) 269.93 (1.91)
40–49 73 163.40 (2.17) 0.08* 266.49 (2.21) 0.02*
.50 35 157.31(3.20) 260.37 (3.26)
Sex
Male 50 160.67 (3.05) 265.78 (3.12)
Female 157 163.80 (1.49) 0.37 267.52 (1.53) 0.64
Hypertension status
No 148 161.58 (1.93) 268.31 (1.98)
Yes 59 166.72 (4.00) 0.35 264.06 (4.08) 0.42
HAART duration, months
0–36 60 167.83 (2.56) 269.70 (2.63)
37–72 86 162.65 (1.97) 265.91 (2.01)
.73 61 158.89 (2.38) 0.02* 266.22 (2.45) 0. 57
Current CD4 count
,500 cells/mL 120 163.04 (1.66) 266.80 (1.70)
.501 cells/mL 87 163.05 (1.99) 0.98 267.51 (2.03) 0.78
Nadir CD4 count
,200 cells/mL 184 162.85 (1.29) 266.37 (1.31)
.201 cells/mL 23 164.58 (3.94) 0.67 272.92 (4.01) 0.13
Current HIV viral load
,10,000 copies/ml 195 163.71 (1.25) 266.65 (1.27)
.10,000 copies/ml 12 152.21 (5.64) 0.05 274.40 (5.79) 0.20
Peak HIV viral load
,10,000 copies/ml 59 164.32 (2.37) 268.59 (2.42)
.10,000 copies/ml 148 162.54 (1.45) 0.50 266.51 (1.48) 0.46
Adjusted for age, gender, hypertension status, mean arterial blood pressure (MABP), smoking status, BMI, diastolic BP, associate vessel diameter (i.e. CRVE for CRAE
analyses, and CRAE for CRVE analyses), current CD4 count and nadir CD4 count, current VL and peak VL, HAART duration, HAART regimen, WHO clinical stage (1/2 or 3/
4) and TB status (current or past history vs. no history).
*P-value for test of trend.
doi:10.1371/journal.pone.0051405.t004
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lar calibre. The study design also permitted inclusion of an age/
gender matched control group with a similar socio-demographic
profile as the cases. The hypothesis of accelerated aging in HIV
has received criticism primarily due to limitations in character-
ization of participants, and the possibility of differential exposure
to potential risk factors between HIV-infected and uninfected
populations [16,44,45]. By recruiting from the same community,
we aimed to reduce the likelihood of differential risk exposure.
Despite overall high reproducibility using computer-assisted
methods, many factors may affect vessel measurement, some of
which are inherent. For example, slight changes in vessel diameter
with the cardiac cycle (due to pulsatility) may result in variation in
vessel measurements [46] but fluctuations are small and random
[9], causing non-differential misclassification. Measurement of
vessel diameters from colour retinal photographs may underesti-
mate true vascular width because only the red blood cell column is
measured, and not the peripheral plasma cuff. Other factors relate
to the population studied e.g. clarity of the ocular media and hence
photographs, and the presence of greater retinal pigment, as in
African retinas, may overestimate retinal vessel diameter [47]. Our
study design does not permit conclusions about the temporal
relationship between changes in retinal calibre and subsequent risk
of morbidity (e.g. cardiovascular events) or mortality from these
data. In addition, we cannot make any inference about whether
HIV infection or HAART is primarily responsible for the changes
in vascular calibre due to the low proportion of HAART-naı¨ve
individuals recruited. Finally, as both case and control populations
are of African ancestry these findings may not be generalisable to
other ethnic groups.
We present novel data on retinal vascular calibre in HIV. It is
reassuring that our findings are in alignment with a US HIV
cohort [27]. However, compared to US HIV populations, it is
likely that African HIV populations will have experienced a
shorter duration of HAART and initiated treatment at lower CD4
counts. The atherogenic, inflammatory and aging effects of HIV
and HAART and related changes in retinal vascular calibre may
thus follow a different trajectory, with longitudinal data needed to
assess this definitively. It is also unclear whether HIV infection or
treatment with HAART is primarily responsible for changes in
vascular calibre. In addition, epigenetic and genetic variation may
contribute to an individual’s susceptibility to non-HIV age-related
morbidity and to vascular structural changes.
The challenge of managing excess age-related morbidity in
HIV-infected individuals will increase as HIV populations live
longer and HAART coverage expands. Stratification of vascular
risk among HIV-infected individuals, particularly cardiovascular
risk, and implementing preventive strategies will be important
priorities for patient management. Cardiovascular risk assessment
tools already exist such as the Framingham Risk Scores [48],
however, specific tools tailored to HIV-infected populations are
necessary [49]. Measurement of retinal vessel calibre is validated,
non-invasive, and can be performed quickly by non-clinical
personnel. Our data support the hypothesis that retinal vascular
calibre changes occur in HIV infection, reflecting systemic
vascular pathology. Longitudinal studies are needed to confirm
this hypothesis as well as validation studies to explore the role of
retinal vessel measurement as a tool in HIV-related vascular risk
estimation.
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